N
PRTK

Natixis’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Natixis’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-491,724
Closed -$1.09M – 1145
2023
Q2 		$1.09M Buy
+491,724
New +$1.09M 0.01% 510
2023
Q1 		– Sell
-29,006
Closed -$54.2K – 1182
2022
Q4 		$54.2K Buy
+29,006
New +$54.2K ﹤0.01% 859